High-fiber diet to help immunotherapy work better in advanced melanoma
Part of Cancer, Skin clinical trials.
This trial tests if adding extra dietary fiber before and during immunotherapy can change gut bacteria to make the treatment more effective. It is for people with advanced melanoma who are about to start their first immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced melanoma (stage III that can't be removed or stage IV) that has spread
- You are about to start your first immunotherapy treatment
- You are 18 years or older
- You have not had immunotherapy before (unless it was as a preventive treatment and ended at least 6 months ago)
- You are not taking or have recently stopped certain medications like antibiotics, laxatives, or stomach acid reducers
- You have not had major bowel surgery (except appendix removal) and do not have active inflammatory bowel disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether eating a high-fiber diet can improve how well immunotherapy works against melanoma by affecting gut bacteria. If you have melanoma and are starting or have recently started immunotherapy, this study may be relevant.
This trial tests whether adding a postbiotic (a gut-health supplement) to a standard immunotherapy called anti-PD-1 makes it work better for people with advanced melanoma that hasn't been treated yet. It may help shrink tumors or slow the cancer's growth.
This study tests if eating certain prebiotic foods while receiving immunotherapy before melanoma surgery can boost your immune system and improve treatment response. Participants eat study-provided foods and receive standard immunotherapy (ipilimumab with or without nivolumab, or nivolumab with or without relatlimab).
This trial tests if a high-fiber diet and occasional short-term fasting can help melanoma patients respond better to immunotherapy. It aims to improve treatment outcomes by changing gut health.
This trial tests if giving a special capsule of donated bacteria (fecal transplant) alongside standard immunotherapy helps shrink tumors in people with advanced melanoma. It aims to see if adding the bacteria can make the immune therapy work better.
This trial tests whether a special diet low in certain amino acids (building blocks of protein), combined with an immune-boosting antibody drug, can safely shrink stage III melanoma that has spread to lymph nodes. The goal is to see if this combination works better than standard treatment.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.